DexTech Medical AB (XSAT:DEX) Cyclically Adjusted Book per Share: kr1.68 (As of Mar. 2026)


XSAT:DEX DexTech Medical AB XSAT:DEX
17 GF Score
Price kr10.20
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB Cyclically Adjusted Book per Share?

DexTech Medical AB XSAT:DEX -0.49% 17 Cyclically Adjusted Book per Share is kr1.68 as of Mar. 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

DexTech Medical AB's adjusted book value per share for the three months ended in Mar. 2026 was kr1.090. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, DexTech Medical AB's average Cyclically Adjusted Book Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-04), DexTech Medical AB's current stock price is kr10.20. DexTech Medical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr1.68. DexTech Medical AB's Cyclically Adjusted PB Ratio of today is 6.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DexTech Medical AB was 6.31. The lowest was 0.00. And the median was 0.00.


DexTech Medical AB  (XSAT:DEX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DexTech Medical AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.20/1.68
=6.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of DexTech Medical AB was 6.31. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


DexTech Medical AB Cyclically Adjusted Book per Share Related Terms


DexTech Medical AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for DexTech Medical AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexTech Medical AB Cyclically Adjusted Book per Share Chart

DexTech Medical AB Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.89 1.88 1.76

DexTech Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 1.76 1.73 1.70 1.68

XSAT:DEX vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, DexTech Medical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexTech Medical AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Cyclically Adjusted PB Ratio falls into.


XSAT:DEX
17GF Score
DexTech Medical AB XSAT:DEX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DexTech Medical AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.09/133.5600*133.5600
=1.090

Current CPI (Mar. 2026) = 133.5600.

DexTech Medical AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.516 101.019 2.004
201609 1.413 101.138 1.866
201612 2.280 102.022 2.985
201703 2.051 102.022 2.685
201706 1.902 102.752 2.472
201709 1.779 103.279 2.301
201712 1.632 103.793 2.100
201803 1.483 103.962 1.905
201806 1.318 104.875 1.679
201809 1.191 105.679 1.505
201812 1.039 105.912 1.310
201903 0.909 105.886 1.147
201906 1.381 106.742 1.728
201909 1.234 107.214 1.537
201912 1.109 107.766 1.374
202003 0.985 106.563 1.235
202006 0.859 107.498 1.067
202009 0.758 107.635 0.941
202012 0.656 108.296 0.809
202103 0.558 108.360 0.688
202106 0.460 108.928 0.564
202109 0.398 110.338 0.482
202112 2.822 112.486 3.351
202203 2.216 114.825 2.578
202206 2.103 118.384 2.373
202209 2.059 122.296 2.249
202212 1.996 126.365 2.110
202303 1.916 127.042 2.014
202306 1.856 129.407 1.916
202309 1.807 130.224 1.853
202312 1.748 131.912 1.770
202403 1.672 132.205 1.689
202406 1.602 132.716 1.612
202409 1.540 132.304 1.555
202412 1.488 132.987 1.494
202503 1.421 132.825 1.429
202506 1.340 133.699 1.339
202509 1.340 133.480 1.341
202512 1.183 133.390 1.185
202603 1.090 133.560 1.090

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr1.68 mean?
DexTech Medical AB (XSAT:DEX) has a Cyclically Adjusted Book per Share of kr1.68 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on DexTech Medical AB and its competitors.
Is DexTech Medical AB's Cyclically Adjusted Book per Share too high?
DexTech Medical AB's current Cyclically Adjusted Book per Share is kr1.68. Overall, DexTech Medical AB has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
DexTech Medical AB's Cyclically Adjusted Book per Share of kr1.68 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current Cyclically Adjusted Book per Share is kr1.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Cyclically Adjusted Book per Share of kr1.68. The current Cyclically Adjusted Book per Share is kr1.68. DexTech Medical AB's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Cyclically Adjusted Book per Share is kr1.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
17GF Score

Get the complete analysis for XSAT:DEX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.20
Price